1. Home
  2. NIM vs IMUX Comparison

NIM vs IMUX Comparison

Compare NIM & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIM
  • IMUX
  • Stock Information
  • Founded
  • NIM 1992
  • IMUX 2016
  • Country
  • NIM United States
  • IMUX United States
  • Employees
  • NIM N/A
  • IMUX N/A
  • Industry
  • NIM Trusts Except Educational Religious and Charitable
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NIM Finance
  • IMUX Health Care
  • Exchange
  • NIM Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • NIM 111.9M
  • IMUX 94.9M
  • IPO Year
  • NIM N/A
  • IMUX N/A
  • Fundamental
  • Price
  • NIM $9.13
  • IMUX $1.01
  • Analyst Decision
  • NIM
  • IMUX Strong Buy
  • Analyst Count
  • NIM 0
  • IMUX 6
  • Target Price
  • NIM N/A
  • IMUX $13.20
  • AVG Volume (30 Days)
  • NIM 35.4K
  • IMUX 1.3M
  • Earning Date
  • NIM 01-01-0001
  • IMUX 05-20-2025
  • Dividend Yield
  • NIM 3.46%
  • IMUX N/A
  • EPS Growth
  • NIM N/A
  • IMUX N/A
  • EPS
  • NIM N/A
  • IMUX N/A
  • Revenue
  • NIM N/A
  • IMUX N/A
  • Revenue This Year
  • NIM N/A
  • IMUX N/A
  • Revenue Next Year
  • NIM N/A
  • IMUX N/A
  • P/E Ratio
  • NIM N/A
  • IMUX N/A
  • Revenue Growth
  • NIM N/A
  • IMUX N/A
  • 52 Week Low
  • NIM $8.28
  • IMUX $0.83
  • 52 Week High
  • NIM $9.74
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • NIM 47.98
  • IMUX 46.64
  • Support Level
  • NIM $9.08
  • IMUX $0.95
  • Resistance Level
  • NIM $9.22
  • IMUX $1.22
  • Average True Range (ATR)
  • NIM 0.17
  • IMUX 0.12
  • MACD
  • NIM -0.01
  • IMUX -0.01
  • Stochastic Oscillator
  • NIM 31.48
  • IMUX 16.67

About NIM Nuveen Select Maturities Municipal Fund

Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital by investing in an investment-grade quality portfolio of municipal obligations with intermediate characteristics.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: